A Study of IBI363 Combination Therapy in Participants With Advanced Solid Tumors
A Study of IBI363 Combination Therapy in Participants With Advanced Solid Tumors
Not yet recruiting · NCT07124793 · Registry updated 2025-08-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of IBI363 Combination Therapy in Participants With Advanced Solid Tumors | EGFR Mutant NSCLC and Platinum Resistant Ovarian Cancer | Not yet recruiting | Phase 2 | 2025-08-15 | NCT07124793 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Innovent Biologics (Suzhou) Co. Ltd. | 82 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tongji Hospital Affiliated to Tongji Medical College Hust | Wuhan | China | 3 |